Liraglutide (n=10)
semaglutide generally needs no dose adjustment Patients with kidney disease : Generally no dose adjustments needed for either medication, but monitoring is advised People with diabetes : Should be aware of the risk of diabetic retinopathy progression with rapid improvement in blood glucose control
In the pivotal SURPASS clinical trial program for type 2 diabetes, diarrhea was reported in 13-17% of patients receiving tirzepatide, with rates varying by dose
Ninety-five percent of the dietary glutamate is metabolized by intestinal cells in a first pass
These enzymes are responsible for creating prostaglandins, which are chemicals that signal pain and cause inflammation
A little avocado, olive oil, hummus, cheese, nut butter, or salmon can make a small meal more satisfying